153 related articles for article (PubMed ID: 29473247)
1. Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer.
Hamstra DA; Lee KC; Eisbruch A; Sunkara P; Borgonha S; Phillip B; Campbell KCM; Ross BD; Rehemtulla A
Head Neck; 2018 Jul; 40(7):1375-1388. PubMed ID: 29473247
[TBL] [Abstract][Full Text] [Related]
2. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
Henke M; Alfonsi M; Foa P; Giralt J; Bardet E; Cerezo L; Salzwimmer M; Lizambri R; Emmerson L; Chen MG; Berger D
J Clin Oncol; 2011 Jul; 29(20):2815-20. PubMed ID: 21670447
[TBL] [Abstract][Full Text] [Related]
3. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.
Lozano A; Marruecos J; Rubió J; Farré N; Gómez-Millán J; Morera R; Planas I; Lanzuela M; Vázquez-Masedo MG; Cascallar L; Giralt J; Escames G; Valentí V; Grima P; Bosser R; Tarragó C; Mesía R
Clin Transl Oncol; 2021 Sep; 23(9):1801-1810. PubMed ID: 33738704
[TBL] [Abstract][Full Text] [Related]
4. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.
Sharma A; Rath GK; Chaudhary SP; Thakar A; Mohanti BK; Bahadur S
Eur J Cancer; 2012 Apr; 48(6):875-81. PubMed ID: 21741230
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
[TBL] [Abstract][Full Text] [Related]
7. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
8. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
Anderson CM; Lee CM; Saunders DP; Curtis A; Dunlap N; Nangia C; Lee AS; Gordon SM; Kovoor P; Arevalo-Araujo R; Bar-Ad V; Peddada A; Colvett K; Miller D; Jain AK; Wheeler J; Blakaj D; Bonomi M; Agarwala SS; Garg M; Worden F; Holmlund J; Brill JM; Downs M; Sonis ST; Katz S; Buatti JM
J Clin Oncol; 2019 Dec; 37(34):3256-3265. PubMed ID: 31618127
[TBL] [Abstract][Full Text] [Related]
9. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
[TBL] [Abstract][Full Text] [Related]
10. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.
Cerchietti LC; Navigante AH; Lutteral MA; Castro MA; Kirchuk R; Bonomi M; Cabalar ME; Roth B; Negretti G; Sheinker B; Uchima P
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1330-7. PubMed ID: 16765532
[TBL] [Abstract][Full Text] [Related]
11. A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis.
Hawley P; Hovan A; McGahan CE; Saunders D
Support Care Cancer; 2014 Mar; 22(3):751-61. PubMed ID: 24221577
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
[TBL] [Abstract][Full Text] [Related]
13. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
14. Assessment and prevalence of concomitant chemo-radiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
Minhas S; Sajjad A; Chaudhry RM; Zahid H; Shahid A; Kashif M
Turk J Med Sci; 2021 Apr; 51(2):675-684. PubMed ID: 33155791
[TBL] [Abstract][Full Text] [Related]
15. Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.
Marucci L; Farneti A; Di Ridolfi P; Pinnaro P; Pellini R; Giannarelli D; Vici P; Conte M; Landoni V; Sanguineti G
Head Neck; 2017 Sep; 39(9):1761-1769. PubMed ID: 28560780
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological protection from radiation ± cisplatin-induced oral mucositis.
Cotrim AP; Yoshikawa M; Sunshine AN; Zheng C; Sowers AL; Thetford AD; Cook JA; Mitchell JB; Baum BJ
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1284-90. PubMed ID: 22197226
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial.
Lalla RV; Solé S; Becerra S; Carvajal C; Bettoli P; Letelier H; Santini A; Vargas L; Cifuentes A; Larsen F; Jara N; Oyarzún J; Feinn R; Bustamante E; Martínez B; Rosenberg D; Galván T
Support Care Cancer; 2020 Dec; 28(12):5871-5879. PubMed ID: 32266567
[TBL] [Abstract][Full Text] [Related]
18. Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial.
Sio TT; Le-Rademacher JG; Leenstra JL; Loprinzi CL; Rine G; Curtis A; Singh AK; Martenson JA; Novotny PJ; Tan AD; Qin R; Ko SJ; Reiter PL; Miller RC
JAMA; 2019 Apr; 321(15):1481-1490. PubMed ID: 30990550
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
[TBL] [Abstract][Full Text] [Related]
20. Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study.
Dechaphunkul T; Arundon T; Raungkhajon P; Jiratrachu R; Geater SL; Dechaphunkul A
Clin Nutr; 2022 Feb; 41(2):433-440. PubMed ID: 35007812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
